Dapsone USP from Japan
Dapsone is an organo-sulfur antibacterial drug used for leprosy and dermatitis herpetiformis treatment. Its diphenylsulfone structure features sulfur directly linked to aromatic carbons, characteristic of heading 2930 organo-sulfur compounds. Designated as a drug in subheading 2930.90.92.35.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6211.3%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Provide WHO prequalification if applicable and methemoglobinemia risk disclosures for FDA review
• Label clearly as human pharmaceutical to prevent veterinary reclassification
• Avoid bulk packaging over 25kg without special stability permits